Pioneers in the mapping of all active compounds of the cannabis plant (cannabinoids, terpenes, flavonoids). CannaSoul has partnered with some of the world’s foremost medical cannabis companies to provide access to a wide range of analytics and R&D capabilities rarely found in the industry (17025 accreditation is for 17 CNBs and 36 terpenes)

CannaSoul is at the vanguard of companies able to provide the necessary, crucial data required to meet the standards of effective, safe, and reliable cannabis-based medical products, treatments, and pharmaceuticals.


Unparalleled, precise and comprehensive phytocannabinoid, endocannabinoid, and terpene analyses, incorporating analysis of over 100 terpenes and cannabinoids.
Endocannabinoid analysis on an extensive range of matrixes. We’re proud to be the first laboratory to offer this
Well-developed analytic capabilities for all plant material and its products, as well as endocannabinoids in serum, plasma, and biological tissues (PK studies)
The ability and expertise to accompany pharmacokinetic studies (PK) for phytocannabinoids and the effect on the endocannabinoid system.


Quantitation of the 17 major cannabinoids (logo ISRAC)
2) Full cannabinoids profile – over 90 cannabinoids with high sensitivity in plant material, different products and biological samples.


1) Quantitation of over 35 of the main terpenes in cannabis
2) Quantitation of over 90 terpenes, providing a full terpene profile


1) Quantitation of over 30 endocannabinoids and THC metabolites (in the future GCLP logo)
2) Quantification of over 90 endocannabinoids